Amundi Vir Biotechnology, Inc. Transaction History
Amundi
- $275 Billion
- Q4 2024
A detailed history of Amundi transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Amundi holds 46,614 shares of VIR stock, worth $320,238. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,614
Previous 14,373
224.32%
Holding current value
$320,238
Previous $107,000
219.63%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIR
# of Institutions
231Shares Held
90MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$115 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$90.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$34.9 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$22.1 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $911M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...